Race/Gender-Specific Densitometry Database Warning Endorsed By Panel
This article was originally published in The Gray Sheet
Gender and ethnicity-specific databases used with bone densitometry/sonometry devices to assess fracture risk should include cautionary language that their relevance has not undergone sufficient clinical evaluation, FDA's Radiological Devices Panel agreed at a May 17 meeting in Rockville, Maryland.
You may also be interested in...
Patient databases used in support of premarket approval of bone densitometry/sonometry devices in assessing fracture risk should consist of Caucasian females 20-29, according to an FDA final guidance.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.